Clinical Trial Update: Apatinib for Resectable Colorectal Cancer [NA]

View source ↗

Summary

This clinical trial update indicates that the apatinib trial for resectable colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Nanchong Central Hospital | Conditions: Apatinib, Outcome, Fatal | NA | Status: WITHDRAWN